
Salarius Pharmaceuticals Inc (SLRX)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -49.901 | -70.125 | -96.609 | -57.124 | -39.917 | -38.829 | -113.933 | -118.118 |
Return on Equity (%) | -52.133 | -77.885 | -114.21 | -69.835 | -47.337 | -41.943 | -128.729 | -160.069 |
Return on Invested Capital (%) | -53.582 | -78.83 | -115.383 | -84.526 | -48.389 | -43.553 | -97.391 | -166.667 |
Operating Margin (%) | -3906.33 | -2702.826 | -2615.99 | -200.231 | -140.436 | -693.913 | N/A | N/A |
Net Profit Margin (%) | -3906.33 | -2702.826 | -2615.99 | -200.173 | -148.079 | -693.913 | N/A | N/A |
Book Value Per Share | 3.536 | 1.635 | 0.514 | 0.38 | 0.558 | 0.66 | 4.603 | 1.343 |
Earnings Per Share | -2.354 | -1.935 | -1.213 | -1.538 | -0.325 | -0.282 | -14.011 | -3.185 |
Cash Per Share | 1.336 | 1.078 | 0.544 | 0.829 | 0.467 | 0.646 | 5.366 | 1.498 |
Working Capital Per Share | 3.492 | 1.612 | 0.51 | 0.306 | 0.547 | 0.62 | 4.545 | 1.326 |
Operating Profit Per Share | 0.037 | 0.061 | 0.035 | 0.768 | 0.22 | 0.041 | N/A | N/A |
EBIT Per Share | -2.354 | -1.935 | -1.213 | -1.538 | -0.309 | -0.282 | -14.011 | -3.185 |
EBITDA Per Share | -2.354 | -1.935 | -1.213 | -1.538 | -0.309 | -0.282 | -14.011 | -3.185 |
Free Cash Flow Per Share | -2.338 | -1.947 | -1.226 | -1.544 | -0.326 | -0.283 | -13.349 | -3.188 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 16,77M | 17,8M | 18,07M | 4,51M | 23,81M | 45,24M | 2,26M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 2,26M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 1,42M |
Ratio cours/bénéfice | -0,11 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 0,22 |
Ratio prix/valeur comptable | 0,25 |
Rendement de dividende | - |
Actions en circulation | 1,44M |
Volume moyen (1 semaine) | 45,26k |
Volume moyen (1 mois) | 197,54k |
Variation sur 52 semaines | -82,88% |
Plus haut sur 52 semaines | 7,20 |
Plus bas sur 52 semaines | 0,906 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales